Description
STEIN Fireside Podcast: Bell Labs, Brain-Computer Interfaces & DBS Innovation with Hemant Bokil, S1-Ep21
How does someone go from studying mathematical physics to helping develop cutting-edge neurotechnology?
In this episode of the STEIN Fireside Podcast Series, with Dr. Kai Miller, Matt Baker, and Bryan Klassen sit down with Hemant Bokil to discuss his unique journey from mathematics and theoretical physics into computational neuroscience, Brain-Computer Interfaces (BCIs), and eventually Boston Scientific's Deep Brain Stimulation (DBS) program.
The conversation explores early neuroscience research, Bell Labs innovation culture, the development of the Chronux toolbox, writing Observed Brain Dynamics, and the challenges of translating scientific discoveries into real-world medical technologies. Hemant also shares insights into DBS programming, neurotechnology regulation, imaging-guided therapies, and the future of adaptive brain stimulation.
Whether you're interested in neuroscience, engineering, medical devices, or scientific careers, this episode offers a fascinating look at how ideas move from theory to patient care.
Like, Subscribe, and Share if you enjoy conversations on neuroscience, neurosurgery, neurotechnology, and innovation.
00:00 Introduction & Meet Hemant Bokil
00:31 From Mathematics to Theoretical Physics
01:34 Discovering Neuroscience
03:33 Modeling Neural Systems and Brain Activity
06:48 Early Brain-Computer Interface Research
08:09 Bell Labs and the Culture of Innovation
09:47 Lessons from the Hendrik Schön Scandal
10:52 Neural Decoding and BCI Development
13:08 Building the Chronux Neuroscience Toolbox
14:19 Entrepreneurship and SBIR Funding
16:16 Writing Observed Brain Dynamics
19:05 Mentorship and Scientific Collaboration
21:25 Joining Boston Scientific
23:01 Advances in Deep Brain Stimulation Technology
25:33 Why DBS Uses 130 Hz Stimulation
27:43 Bringing Neurotechnology to Market
29:06 Medical Device Regulation and Clinical Evidence
31:06 DBS Practice Around the World
32:55 The Future of Adaptive DBS and Brain Therapies
37:39 Final Thoughts and Closing Remarks